Physicochemical characterization of terbinafine-cyclodextrin complexes in solution and in the solid state

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 66, Issue 3, 2010, Pages 393-402

  Uzqueda, Maite ^a   Martín, Carmen ^a   Zornoza, Arantza ^a   Sánchez, Miguel ^a   Vélaz, Itziar ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Cyclodextrins; Dissolution rate; Solid complexes; Solubility diagrams; Terbinafine

Indexed keywords

EID: 77952293446     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-009-9656-0     Document Type: Article

References (44)

1. Balfour, J. A., Faulds, D.: Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in superficial mycoses. Drugs 43(2), 259-284 (1992).
2. Schuster, I., Ryder, N. S.: Allylamines-mode and selectivity of action compared to azole antifungals and biological fate in mammalian organisms. J. Dermatol. Treat. 1(2), 7-9 (1990).
3. Hector, R. F.: An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals. Clin. Tech. Small Anim. Pract. 20, 240-249 (2005).
4. Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98, 1743-1753 (1998).
5. Hirayama, F., Uekama, K.: Cyclodextrin-based controlled drug release system. Adv. Drug Deliv. Rev. 36, 125-141 (1999).
6. Loftsson, T., Jarho, P., Másson, M., Järvinen, T.: Cyclodextrins in drug delivery. Expert Opin. Drug Deliv. 2, 335-351 (2005).
7. Uekama, K.: Recents aspects of pharmaceutical application of cyclodextrins. J. Incl. Phenom. Macrocycl. Chem. 44, 3-7 (2002).
8. Szeman, J., Ueda, H., Szejtli, J., Fenyvesi, E., Watanabe, Y., Machida, Y., Nagai, T.: Enhanced percutaneous absorption of homogenized tolnaftate/β-cyclodextrin polymer ground mixture. Drug Des. Deliv. 1, 325-332 (1987).
9. Tenjarla, S., Puranajoti, P., Kasina, R., Mandal, T.: Preparation, characterization, and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery. J. Pharm. Sci. 87(4), 425-429 (1998).
10. Ahmed, M. O., El-Gibaly, I., Ahmed, S. M.: Effect of cyclodextrins on the physicochemical properties and antimycotic activity of clotrimazole. Int. J. Pharm. 171, 111-121 (1998).
11. Taneri, F., Güneri, T., Aigner, Z., Erös, I., Kata, M.: Improvement of the physicochemical properties of clotrimazole by cyclodextrin complexation. J. Incl. Phenom. Macrocycl. Chem. 46, 1-13 (2003).
12. Taneri, F., Güneri, T., Aigner, Z., Berkesi, O., Kata, M.: Thermoanalytical studies on complexes of clotrimazole with cyclodextrins. J. Therm. Anal. Calorim. 76, 471-479 (2004).
13. Taneri, F., Güneri, T., Aigner, Z., Kata, M.: Improvement of the physicochemical properties of ketoconazole through complexation with cyclodextrin derivatives. J. Incl. Phenom. Macrocycl. Chem. 44, 257-260 (2002).
14. Taneri, F., Güneri, T., Aigner, Z., Kata, M.: Influence of cyclodextrin complexation on the physicochemical and biopharmaceutical properties of ketoconazole. J. Incl. Phenom. Macrocycl. Chem. 47, 15-23 (2003).
15. Taraszewska, J., Kozbial, M.: Complexation of ketoconazol by native and modified cyclodextrins. J. Incl. Phenom. Macrocycl. Chem. 53, 155-161 (2005).
16. Miyake, K., Irie, T., Arima, H., Hirayama, F., Uekama, K., Hirano, M., Okamoto, Y.: Characterization of itraconazole/2-hydroxypropyl-β-cyclodextrin inclusion complex in aqueous propylene glycol solution. Int. J. Pharm. 179, 237-245 (1999).
17. Brewster, M. E., Vandecruys, R., Peeters, J., Neeskens, P., Verreck, G., Loftsson, T.: Comparative interaction of 2-hydroxypropyl-β-cyclodextrin and sulfobutylether-β-cyclodextrin with itraconazole: phase solubility-behaviour and stabilization of supersaturated drug solutions. Eur. J. Pharm. Sci. 34, 94-103 (2008).
18. Mura, P., Faucci, M. T., Manderioli, A., Bramanti, G.: Influence of the preparation method on the physicochemical properties of binary systems of econazole with cyclodextrins. Int. J. Pharm. 193, 85-95 (1999).
19. 1NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with α-cyclodextrin in the presence of malic acid. J. Pharm. Biomed. Anal. 23, 25-31 (2000).
20. Al-Marzouqi, A. H., Elwy, H. M., Shehadi, I., Adem, A.: Physicochemical properties of antifungal drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques. J. Pharm. Biomed. Anal. 49, 227-233 (2009).
21. Denadai, A. M. L., Teixeira, K. I., Santoro, M. M., Pimenta, A. M. C., Cortés, M. E., Sinisterra, R. D.: Supramolecular self-assembly of β-cyclodextrin: an effective carrier of the antimicrobial agent clorhexidine. Carbohydr. Res. 342, 2286-2296 (2007).
22. Fouda, M. M. G., Knittel, D., Hipler, U.-C., Elsner, P., Schollmeyer, E.: Antimycotic influence of β-cyclodextrin complexes-in vitro measurements using laser nephelometry in microtiter plates. Int. J. Pharm. 311, 113-121 (2006).
23. Noomen, A., Hbaieb, S., Parrot-Lopez, H., Kalfat, R., Fessi, H., Amdouni, N., Chevalier, Y.: Emulsions of β-cyclodextrins grafted to silicone for the transport of antifungal drugs. Mater. Sci. Eng. C 28, 705-715 (2008).
24. Uzqueda, M., Martín, C., Zornoza, A., Sánchez, M., Martínez-Ohárriz, M. C., Vélaz, I.: Characterization of complexes between naftifine and cyclodextrins in solution and in the solid state. Pharm. Res. 23(5), 980-988 (2006).
25. Connors, K. A.: Binding constants. The measurement of molecular complex stability. Wiley, New York (1987).
26. González-Gaitano, G., Rodríguez, P., Isasi, J. R., Fuentes, M., Sánchez, M.: The aggregation of cyclodextrins as studied by photon correlation spectroscopy. J. Incl. Phenom. Macrocycl. Chem. 44, 101-105 (2002).
27. Higuchi, T., Connors, K. A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965).
28. Madrid, J. M., Pozuelo, J., Mendicuti, F., Matice, W. L.: Molecular mechanics study of the inclusion complexes of 2-methyl naphthoate with α- and β-cyclodextrins. J. Colloid Interface Sci. 193, 112-120 (1997).
29. Estrada, E., Perdomo-López, I., Torres-Labandeira, J. J.: Combination of 2D-, 3D-connectivity and quantum chemical descriptors in QSPR. Complexation of α- and β-cyclodextrin with benzene derivatives. J. Chem. Inf. Comput. Sci. 41(6), 1561-1568 (2001).
30. Szente, L.: Preparation of cyclodextrin complexes. In: Szejtli, J., Osa, T. (eds.) Comprehensive supramolecular chemistry Vol 3. Cyclodextrins, pp. 243-252. Elsevier Science Ltd., Oxford (1996).
31. Hasimoto, H.: Preparation, structure, property and application of branched cyclodextrins. In: Duchêne, D. (ed.) New trends in cyclodextrins and derivatives, pp. 99-156. Editions de Santé, Paris (1991).
32. Liu, L., Zhu, S.: Preparation and characterization of inclusion complexes of prazosin hydrochloride with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. J. Pharm. Biomed. Anal. 40, 122-127 (2006).
33. Hunt, M. A., Rusa, C. C., Tonelli, A. E., Balik, C. M.: Structure and stability of columnar cyclomaltohexaose (α-cyclodextrin) hydrate. Carbohydr. Res. 339, 2805-2810 (2004).
34. Rusa, C. C., Bullions, T. A., Fox, J., Porbeni, F. E., Wang, X., Tonelli, A. E.: Inclusion compound formation with a new columnar cyclodextrin host. Langmuir 18, 10016-10023 (2002).
35. Takeo, K., Kuge, T.: Complexes of starchy materials with organic compounds. Part III. X-ray studies on amylase and cyclodextrin complexes. Agric. Biol. Chem. 33(8), 1174-1180 (1969).
36. Hunt, M. A., Rusa, C. C., Tonelli, A. E., Balik, C. M.: Structure and stability of columnar cyclomaltooctaose (γ-cyclodextrin) hydrate. Carbohydr. Res. 340, 1631-1637 (2005).
37. Harata, K.: Crystallographic studies. In: Szejtli, J., Osa, T. (eds.) Comprehensive supramolecular chemistry Vol 3. Cyclodextrins, pp. 279-304. Elsevier Science Ltd., Oxford (1996).
38. Saenger, W., Jacob, J., Gessler, K., Steiner, T., Hoffmann, D., Sanbe, H., Koizumi, K., Smith, S. H., Takaha, T.: Structures of the common cyclodextrins and their larger analogues beyond the doughnut. Chem. Rev. 98, 1787-1802 (1998).
39. Cappello, B., Di Maio, C., Iervolino, M.: Investigation on the interaction of bendazac with β-, hydroxypropyl-β- and γ-cyclodextrins. J. Incl. Phenom. Macrocycl. Chem. 43, 251-257 (2002).
40. Alberti, I., Kalia, Y. N., Naik, A., Bonny, J. D., Guy, R. H.: In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. J. Control. Rel. 71, 319-327 (2001).
41. Ruan, L. P., Yu, B. Y., Fu, G. M., Zhu, D. N.: Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J. Pharm. Biomed. Anal. 38, 457-464 (2005).
42. Mura, P., Zerrouk, N., Mennini, N., Maestrelli, F., Chemtob, C.: Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties. Eur. J. Pharm. Sci. 19, 67-75 (2003).
43. Craig, D. Q. M.: The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 231, 131-144 (2002).
44. Loftsson, T., Brewster, M. E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017-1025 (1996).